TickerFacts.

Haoxi Health Technology Ltd (HAO): R&D Expense

Annual figures by period end, from SEC filings.

$79.5K
Year ended 2025-06-30
-8.1%
3-year compound annual growth
$102.5K2022-06-30: $102.5K2023-06-30: $58.2K2024-06-30: $80.0K2025-06-30: $79.5K$79.5K
2022-06-30 R&D Expense (USD) 2025-06-30
Period endedR&D ExpenseChange YoYSource filing
2025-06-30$79.5K-0.6%2025-10-20, From 2024-07-01
2024-06-30$80.0K+37.5%2025-10-20, From 2023-07-01
2023-06-30$58.2K-43.3%2025-10-20, From 2022-07-01
2022-06-30$102.5Kn/a2024-10-29, From 2021-07-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Advertising Agencies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Haoxi Health Technology Ltd (HAO)2025-06-30$79.5K-0.6%
Criteo S.A. (CRTO)2025-12-31$283.30M+1.4%

Compare HAO, CRTO side by side · Screen every company in Services-Advertising Agencies ↗